David Cavalier - Net Worth and Insider Trading
David Cavalier Net Worth
The estimated net worth of David Cavalier is at least $6,516 dollars as of 2024-11-13. David Cavalier is the Director of Anixa Biosciences Inc and owns about 2,000 shares of Anixa Biosciences Inc (ANIX) stock worth over $6,516. Details can be seen in David Cavalier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Cavalier has not made any transactions after 2019-04-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Cavalier
David Cavalier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Cavalier owns 2 companies in total, including Anixa Biosciences Inc (ANIX) , and Aeolus Pharmaceuticals Inc (AOLS) .
Click here to see the complete history of David Cavalier’s form 4 insider trades.
Insider Ownership Summary of David Cavalier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANIX | Anixa Biosciences Inc | 2019-04-29 | director |
| AOLS | Aeolus Pharmaceuticals Inc | 2013-05-08 | director |
David Cavalier Latest Holdings Summary
David Cavalier currently owns a total of 1 stock. David Cavalier owns 2,000 shares of Anixa Biosciences Inc (ANIX) as of April 29, 2019, with a value of $6,516.
Latest Holdings of David Cavalier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANIX | Anixa Biosciences Inc | 2019-04-29 | 2,000 | 3.26 | 6,516 |
Holding Weightings of David Cavalier
David Cavalier Form 4 Trading Tracker
According to the SEC Form 4 filings, David Cavalier has made a total of 0 transactions in Anixa Biosciences Inc (ANIX) over the past 5 years. The most-recent trade in Anixa Biosciences Inc is the acquisition of 2,000 shares on April 29, 2019, which cost David Cavalier around $8,420.
Insider Trading History of David Cavalier
- 1
David Cavalier Trading Performance
GuruFocus tracks the stock performance after each of David Cavalier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Cavalier is 8.77%. GuruFocus also compares David Cavalier's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Cavalier within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Cavalier's insider trading performs compared to the benchmark.
Performance of David Cavalier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.37 | | | | | |
| Relative Return to S&P 500(%) | 3.07 | | | | | |
David Cavalier Ownership Network
Ownership Network List of David Cavalier
Ownership Network Relation of David Cavalier
David Cavalier Owned Company Details
What does Anixa Biosciences Inc do?
Who are the key executives at Anixa Biosciences Inc?
David Cavalier is the director of Anixa Biosciences Inc. Other key executives at Anixa Biosciences Inc include director & Chief Executive Officer Amit Kumar , COO & CFO Michael Catelani , and Chief Operating Officer Tisha Stender .
Anixa Biosciences Inc (ANIX) Insider Trades Summary
Over the past 18 months, David Cavalier made no insider transaction in Anixa Biosciences Inc (ANIX). Other recent insider transactions involving Anixa Biosciences Inc (ANIX) include a net purchase of 73,306 shares made by Titterton Lewis H Jr , a net purchase of 43,200 shares made by Amit Kumar , and a net purchase of 15,000 shares made by Arnold M Baskies .
In summary, during the past 3 months, insiders sold 0 shares of Anixa Biosciences Inc (ANIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,800 shares of Anixa Biosciences Inc (ANIX) were sold and 155,056 shares were bought by its insiders, resulting in a net purchase of 143,256 shares.
Anixa Biosciences Inc (ANIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anixa Biosciences Inc Insider Transactions
David Cavalier Mailing Address
Above is the net worth, insider trading, and ownership report for David Cavalier. You might contact David Cavalier via mailing address: C/o Aeolus Pharmaceuticals, Inc., 23811 Inverness Place, Laguna Niguel Ca 92677.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
